Every trade that managers of BibbInstruments AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for BibbInstruments AB logged 4 filings by 3 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €309. Biggest ticket of the year: €309, sold by Fredrik Lindblad and made public on 14 April 2026 (0.0032% of market cap).
Typically, a trade is published a median of 3 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (890 companies, median 7 filings), a count of 4 filings is below the norm. Our records for BibbInstruments AB go back to 2025, with no purchases and 1 sale on the open market in total.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
6 of 6 declarations
BibbInstruments AB is a company specializing in the healthcare and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).
Purchases our model currently ranks for the recommendations list.
All recommendations